Trial
NCT00290407
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Leukemia, Lymphocytic, Chronic
Intervention
Rituximab
Why stopped
terminated due to lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-04